April 12 (Reuters) - Resverlogix Corp RVX.TO : * HEALTH CANADA ISSUES RESVERLOGIX AUTHORIZATION TO BEGIN IMMEDIATE CLINICAL STUDIES OF APABETALONE FOR COVID-19 * RESVERLOGIX CORP -...
March 12 (Reuters) - Resverlogix Corp RVX.TO : * RESVERLOGIX ANNOUNCES CHANGE IN FISCAL YEAR-END TO DECEMBER 31
Dec 22 (Reuters) - Resverlogix Corp RVX.TO : * RESVERLOGIX ANNOUNCES APABETALONE TREATMENT PRIOR TO SARS-COV-2 (COVID-19) EXPOSURE SIGNIFICANTLY REDUCES VIRAL INFECTION – CONFIRMS...
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely looking...
Canadian GDP released on Tuesday Statistics Canada will release the latest gross domestic product data for July on Tuesday morning. Canada’s real GDP for the second quarter,...
Resverlogix Corp. is a Canada-based clinical biotechnology company that is focused on improving the lives of patients with chronic illnesses. The Company is developing apabetalone (RVX-208), a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that regulates disease-causing genes. Apabetalone is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. The selective inhibition of apabetalone on BD2 produces a specific set of biological effects for patients with chronic disease, including cardiovascular disease (CVD) and associated comorbidities, and COVID-19. The Company is in the development stage as it is focused on research and development. The Company has not earned any revenue.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 8.88 | 8.91 | 8.08 | 0.00 | 0.00% | 0.00 | Toronto | |||
| 2.40 | 2.58 | 2.38 | -0.04 | -1.64% | 832.09K | Toronto | |||
| 1.24 | 1.24 | 1.21 | +0.04 | +3.33% | 167.97K | Toronto | |||
| 7.65 | 7.84 | 7.56 | -0.03 | -0.39% | 227.55K | Toronto | |||
| 4.28 | 4.35 | 4.23 | 0.00 | 0.00% | 4.37K | TSXV | |||
| 0.63 | 0.68 | 0.62 | 0.00 | 0.00% | 66.00K | TSXV | |||
| 0.05 | 0.06 | 0.05 | 0.00 | 0.00% | 0.00 | CSE | |||
| 0.93 | 0.94 | 0.83 | +0.030 | +3.33% | 2.47M | Toronto | |||
| 0.38 | 0.395 | 0.375 | -0.0300 | -7.32% | 34.50K | TSXV | |||
| 12.86 | 13.12 | 12.81 | +0.05 | +0.39% | 451.78K | Toronto | |||
| 5.78 | 5.78 | 5.71 | 0.00 | 0.00% | 0.00 | Toronto | |||
| 0.03 | 0.03 | 0.03 | 0.00 | 0.00% | 0.00 | TSXV | |||
| 0.66 | 0.66 | 0.65 | 0.00 | 0.00% | 0.00 | Toronto | |||
| 38.04 | 38.75 | 37.98 | -0.31 | -0.81% | 121.22K | Toronto | |||
| 0.115 | 0.12 | 0.115 | -0.015 | -11.54% | 38.75K | TSXV |